{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T00:21:56Z","timestamp":1778199716436,"version":"3.51.4"},"reference-count":58,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004359","name":"Swedish Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007687","name":"Swedish Society of Medicine","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007687","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008444","name":"OE and Edla Johanssons vetenskapliga stiftelse","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008444","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010819","name":"Stiftelsen Tornspiran","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010819","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005390","name":"ALF-agreement","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005390","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001034","name":"ALF","doi-asserted-by":"publisher","award":["723131"],"award-info":[{"award-number":["723131"]}],"id":[{"id":"10.13039\/501100001034","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["atherosclerosis-journal.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1016\/j.atherosclerosis.2019.06.903","type":"journal-article","created":{"date-parts":[[2019,6,15]],"date-time":"2019-06-15T19:02:11Z","timestamp":1560625331000},"page":"122-133","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"special_numbering":"C","title":["Stimulation of alpha 7 nicotinic acetylcholine receptor (\u03b17nAChR) inhibits atherosclerosis via immunomodulatory effects on myeloid cells"],"prefix":"10.1016","volume":"287","author":[{"given":"Marcus A.","family":"Ulleryd","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Filip","family":"Mj\u00f6rnstedt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dimitra","family":"Panagaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li Jin","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kajsa","family":"Engevall","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saray","family":"Guti\u00e9rrez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yixin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li-Ming","family":"Gan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Holger","family":"Nilsson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erik","family":"Micha\u00eblsson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2569-2977","authenticated-orcid":false,"given":"Maria E.","family":"Johansson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.atherosclerosis.2019.06.903_bib1","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1038\/ni.2001","article-title":"The immune system in atherosclerosis","volume":"12","author":"Hansson","year":"2011","journal-title":"Nat. Immunol."},{"issue":"8","key":"10.1016\/j.atherosclerosis.2019.06.903_bib2","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1161\/01.ATV.19.8.1979","article-title":"Heart rate variability and progression of coronary atherosclerosis","volume":"19","author":"Huikuri","year":"1999","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"4","key":"10.1016\/j.atherosclerosis.2019.06.903_bib3","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/0002-9149(87)90795-8","article-title":"Decreased heart rate variability and its association with increased mortality after acute myocardial infarction","volume":"59","author":"Kleiger","year":"1987","journal-title":"Am. J. Cardiol."},{"issue":"11","key":"10.1016\/j.atherosclerosis.2019.06.903_bib4","doi-asserted-by":"crossref","first-page":"2850","DOI":"10.1161\/01.CIR.94.11.2850","article-title":"Impact of reduced heart rate variability on risk for cardiac events. The Framingham Heart Study","volume":"94","author":"Tsuji","year":"1996","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.atherosclerosis.2019.06.903_bib5","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0174974","article-title":"The association between autonomic dysfunction, inflammation and atherosclerosis in men under investigation for carotid plaques","volume":"12","author":"Ulleryd","year":"2017","journal-title":"PLoS One"},{"issue":"6785","key":"10.1016\/j.atherosclerosis.2019.06.903_bib6","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1038\/35013070","article-title":"Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin","volume":"405","author":"Borovikova","year":"2000","journal-title":"Nature"},{"issue":"6921","key":"10.1016\/j.atherosclerosis.2019.06.903_bib7","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1038\/nature01339","article-title":"Nicotinic acetylcholine receptor [alpha]7 subunit is an essential regulator of inflammation","volume":"421","author":"Wang","year":"2003","journal-title":"Nature"},{"issue":"12","key":"10.1016\/j.atherosclerosis.2019.06.903_bib8","doi-asserted-by":"crossref","first-page":"2632","DOI":"10.1161\/ATVBAHA.114.303892","article-title":"alpha7 Nicotinic acetylcholine receptor is expressed in human atherosclerosis and inhibits disease in mice--brief report","volume":"34","author":"Johansson","year":"2014","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"3","key":"10.1016\/j.atherosclerosis.2019.06.903_bib9","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0124584","article-title":"Reduced size and macrophage content of advanced atherosclerotic lesions in mice with bone marrow specific deficiency of alpha 7 nicotinic acetylcholine receptor","volume":"10","author":"Lee","year":"2015","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2019.06.903_bib10","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1111\/jth.12765","article-title":"Hematopoietic \u03b17 nicotinic acetylcholine receptor deficiency increases inflammation and platelet activation status, but does not aggravate atherosclerosis","volume":"13","author":"Kooijman","year":"2015","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.atherosclerosis.2019.06.903_bib11","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.atherosclerosis.2017.08.010","article-title":"Nicotinic acetylcholine receptor alpha 7 stimulation dampens splenic myelopoiesis and inhibits atherogenesis in Apoe(-\/-) mice","volume":"265","author":"Al-Sharea","year":"2017","journal-title":"Atherosclerosis"},{"issue":"2\u20133","key":"10.1016\/j.atherosclerosis.2019.06.903_bib12","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.vph.2014.03.006","article-title":"Stimulation of alpha7 nicotinic acetylcholine receptor by AR-R17779 suppresses atherosclerosis and aortic aneurysm formation in apolipoprotein E-deficient mice","volume":"61","author":"Hashimoto","year":"2014","journal-title":"Vasc. Pharmacol."},{"issue":"6","key":"10.1016\/j.atherosclerosis.2019.06.903_bib13","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1161\/01.ATV.19.6.1518","article-title":"Monocyte chemoattractant protein-1 accelerates atherosclerosis in apolipoprotein E-deficient mice","volume":"19","author":"Aiello","year":"1999","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"11","key":"10.1016\/j.atherosclerosis.2019.06.903_bib14","doi-asserted-by":"crossref","first-page":"2733","DOI":"10.1161\/ATVBAHA.111.235721","article-title":"CCL20 is increased in hypercholesterolemic subjects and is upregulated by LDL in vascular smooth muscle cells","volume":"31","author":"Calvayrac","year":"2011","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"12","key":"10.1016\/j.atherosclerosis.2019.06.903_bib15","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1161\/01.CIR.0000028590.02477.6F","article-title":"Deposition of platelet RANTES triggering monocyte recruitment requires P-selectin and is involved in neointima formation after arterial injury","volume":"106","author":"Schober","year":"2002","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.atherosclerosis.2019.06.903_bib16","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1002\/emmm.201201717","article-title":"Distinct functions of chemokine receptor axes in the atherogenic mobilization and recruitment of classical monocytes","volume":"5","author":"Soehnlein","year":"2013","journal-title":"EMBO Mol. Med."},{"issue":"1","key":"10.1016\/j.atherosclerosis.2019.06.903_bib17","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1172\/JCI28549","article-title":"Monocyte subsets differentially employ CCR2, CCR5, and CX3CR1 to accumulate within atherosclerotic plaques","volume":"117","author":"Tacke","year":"2007","journal-title":"J. Clin. Investig."},{"issue":"2","key":"10.1016\/j.atherosclerosis.2019.06.903_bib18","first-page":"181","article-title":"The role of the monocyte in atherogenesis: I. Transition of blood-borne monocytes into foam cells in fatty lesions","volume":"103","author":"Gerrity","year":"1981","journal-title":"Am. J. Pathol."},{"issue":"3","key":"10.1016\/j.atherosclerosis.2019.06.903_bib19","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.cardiores.2006.09.005","article-title":"Phagocytosis in atherosclerosis: molecular mechanisms and implications for plaque progression and stability","volume":"73","author":"Schrijvers","year":"2007","journal-title":"Cardiovasc. Res."},{"issue":"8","key":"10.1016\/j.atherosclerosis.2019.06.903_bib20","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1097\/01.hjh.0000174078.95745.77","article-title":"Angiotensin II, type 2 receptor is not involved in the angiotensin II-mediated pro-atherogenic process in ApoE-\/- mice","volume":"23","author":"Johansson","year":"2005","journal-title":"J. Hypertens."},{"issue":"5","key":"10.1016\/j.atherosclerosis.2019.06.903_bib21","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1002\/jlcr.3186","article-title":"Synthesis of three alpha 7 agonists in labeled form","volume":"57","author":"Elmore","year":"2014","journal-title":"J. Label. Comp. Radiopharm."},{"issue":"5","key":"10.1016\/j.atherosclerosis.2019.06.903_bib22","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1161\/CIRCULATIONAHA.116.025684","article-title":"The role of efferocytosis in atherosclerosis","volume":"135","author":"Kojima","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2019.06.903_bib23","series-title":"RNA Sequencing Data Describing Transcriptional Changes in Aorta of ApoE-\/- Mice after Alpha 7 Nicotinic Acetylcholine Receptor (\u03b17nAChR) Stimulation","author":"Ulleryd","year":"2019"},{"issue":"31","key":"10.1016\/j.atherosclerosis.2019.06.903_bib24","doi-asserted-by":"crossref","first-page":"11008","DOI":"10.1073\/pnas.0803237105","article-title":"Splenic nerve is required for cholinergic antiinflammatory pathway control of TNF in endotoxemia","volume":"105","author":"Rosas-Ballina","year":"2008","journal-title":"Proc. Natl. Acad. Sci. Unit. States Am."},{"issue":"1","key":"10.1016\/j.atherosclerosis.2019.06.903_bib25","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1111\/j.1365-2796.2010.02226.x","article-title":"Whole blood cytokine attenuation by cholinergic agonists ex vivo and relationship to vagus nerve activity in rheumatoid arthritis","volume":"268","author":"Bruchfeld","year":"2010","journal-title":"J. Intern. Med."},{"issue":"7\u20138","key":"10.1016\/j.atherosclerosis.2019.06.903_bib26","doi-asserted-by":"crossref","first-page":"195","DOI":"10.2119\/molmed.2009.00039","article-title":"The selective \u03b17 agonist GTS-21 attenuates cytokine production in human whole blood and human monocytes activated by ligands for TLR2, TLR3, TLR4, TLR9, and RAGE","volume":"15","author":"Rosas-Ballina","year":"2009","journal-title":"Mol. Med."},{"issue":"3","key":"10.1016\/j.atherosclerosis.2019.06.903_bib27","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1161\/ATVBAHA.114.304454","article-title":"Pivotal role of serum- and glucocorticoid-inducible kinase 1 in vascular inflammation and atherogenesis","volume":"35","author":"Borst","year":"2015","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"6","key":"10.1016\/j.atherosclerosis.2019.06.903_bib28","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1160\/TH13-01-0017","article-title":"CCR6 selectively promotes monocyte mediated inflammation and atherogenesis in mice","volume":"110","author":"Manthey","year":"2013","journal-title":"Thromb. Haemostasis"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2019.06.903_bib29","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1161\/ATVBAHA.109.198762","article-title":"Absence of myeloid COX-2 attenuates acute inflammation but does not influence development of atherosclerosis in apolipoprotein E null mice","volume":"30","author":"Narasimha","year":"2010","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"3","key":"10.1016\/j.atherosclerosis.2019.06.903_bib30","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1161\/ATVBAHA.116.308715","article-title":"Poliovirus receptor-related 2: a cholesterol-responsive gene affecting atherosclerosis development by modulating leukocyte migration","volume":"37","author":"Rossignoli","year":"2017","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"1","key":"10.1016\/j.atherosclerosis.2019.06.903_bib31","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1432-1033.1991.tb16337.x","article-title":"The molecular action of tumor necrosis factor-alpha","volume":"202","author":"Camussi","year":"1991","journal-title":"Eur. J. Biochem."},{"issue":"3","key":"10.1016\/j.atherosclerosis.2019.06.903_bib32","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1006\/bbrc.1993.2599","article-title":"The chemokine, eotaxin, activates Guinea-pig eosinophils in vitro and causes their accumulation into the lung in vivo","volume":"197","author":"Griffiths-Johnson","year":"1993","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"19","key":"10.1016\/j.atherosclerosis.2019.06.903_bib33","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1161\/CIRCULATIONAHA.105.605121","article-title":"Chemokine CXCL10 promotes atherogenesis by modulating the local balance of effector and regulatory T cells","volume":"113","author":"Heller","year":"2006","journal-title":"Circulation"},{"issue":"7","key":"10.1016\/j.atherosclerosis.2019.06.903_bib34","doi-asserted-by":"crossref","first-page":"2950","DOI":"10.1073\/pnas.89.7.2950","article-title":"The human cytokine I-309 is a monocyte chemoattractant","volume":"89","author":"Miller","year":"1992","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"issue":"1\u20132","key":"10.1016\/j.atherosclerosis.2019.06.903_bib35","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/0304-3940(94)90433-2","article-title":"A novel nicotinic agonist facilitates induction of long-term potentiation in the rat hippocampus","volume":"168","author":"Hunter","year":"1994","journal-title":"Neurosci. Lett."},{"issue":"3","key":"10.1016\/j.atherosclerosis.2019.06.903_bib36","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/S0022-3565(24)37881-4","article-title":"Analysis of 3-(4-hydroxy, 2-Methoxybenzylidene)anabaseine selectivity and activity at human and rat alpha-7 nicotinic receptors","volume":"287","author":"Meyer","year":"1998","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"4","key":"10.1016\/j.atherosclerosis.2019.06.903_bib37","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0214942","article-title":"GTS-21 has cell-specific anti-inflammatory effects independent of alpha7 nicotinic acetylcholine receptors","volume":"14","author":"Garg","year":"2019","journal-title":"PLoS One"},{"issue":"22","key":"10.1016\/j.atherosclerosis.2019.06.903_bib38","doi-asserted-by":"crossref","first-page":"4045","DOI":"10.1021\/jm000249r","article-title":"(\u2212)-Spiro[1-azabicyclo[2.2.2]octane-3,5\u2018-oxazolidin-2\u2018-one], a conformationally restricted analogue of acetylcholine, is a highly selective full agonist at the \u03b17 nicotinic acetylcholine receptor","volume":"43","author":"Mullen","year":"2000","journal-title":"J. Med. Chem."},{"issue":"4","key":"10.1016\/j.atherosclerosis.2019.06.903_bib39","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1124\/pr.113.008581","article-title":"Therapeutic potential of <em>\u03b1<\/em>7 nicotinic acetylcholine receptors","volume":"67","author":"Bertrand","year":"2015","journal-title":"Pharmacol. Rev."},{"issue":"8","key":"10.1016\/j.atherosclerosis.2019.06.903_bib40","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1016\/j.bmcl.2003.09.104","article-title":"Activity of alpha7-selective agonists at nicotinic and serotonin 5HT3 receptors expressed in Xenopus oocytes","volume":"14","author":"Papke","year":"2004","journal-title":"Bioorg. Med. Chem. Lett"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2019.06.903_bib41","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1161\/CIRCULATIONAHA.111.061986","article-title":"Extramedullary hematopoiesis generates Ly-6C(high) monocytes that infiltrate atherosclerotic lesions","volume":"125","author":"Robbins","year":"2012","journal-title":"Circulation"},{"issue":"9","key":"10.1016\/j.atherosclerosis.2019.06.903_bib42","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1161\/CIRCRESAHA.115.304992","article-title":"Loss of one copy of Zfp148 reduces lesional macrophage proliferation and atherosclerosis in mice by activating p53","volume":"115","author":"Sayin","year":"2014","journal-title":"Circ. Res."},{"key":"10.1016\/j.atherosclerosis.2019.06.903_bib43","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.redox.2017.11.013","article-title":"Cholinergic anti-inflammatory pathway inhibits neointimal hyperplasia by suppressing inflammation and oxidative stress","volume":"15","author":"Li","year":"2018","journal-title":"Redox Biol"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2019.06.903_bib44","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1038\/nri2675","article-title":"Macrophage death and defective inflammation resolution in atherosclerosis","volume":"10","author":"Tabas","year":"2010","journal-title":"Nat. Rev. Immunol."},{"issue":"7614","key":"10.1016\/j.atherosclerosis.2019.06.903_bib45","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1038\/nature18935","article-title":"CD47-blocking antibodies restore phagocytosis and prevent atherosclerosis","volume":"536","author":"Kojima","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.atherosclerosis.2019.06.903_bib46","doi-asserted-by":"crossref","first-page":"238","DOI":"10.2119\/molmed.2013.00086","article-title":"The alpha7 nicotinic acetylcholine receptor agonist GTS-21 improves bacterial clearance in mice by restoring hyperoxia-compromised macrophage function","volume":"20","author":"Sitapara","year":"2014","journal-title":"Mol. Med."},{"issue":"7","key":"10.1016\/j.atherosclerosis.2019.06.903_bib47","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1038\/nri1882","article-title":"The immune response in atherosclerosis: a double-edged sword","volume":"6","author":"Hansson","year":"2006","journal-title":"Nat. Rev. Immunol."},{"issue":"5","key":"10.1016\/j.atherosclerosis.2019.06.903_bib48","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1161\/01.ATV.18.5.842","article-title":"Upregulation of VCAM-1 and ICAM-1 at atherosclerosis-prone sites on the endothelium in the ApoE-deficient mouse","volume":"18","author":"Nakashima","year":"1998","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"2","key":"10.1016\/j.atherosclerosis.2019.06.903_bib49","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1161\/01.ATV.17.2.310","article-title":"P-selectin and vascular cell adhesion molecule-1 are focally expressed in aortas of hypercholesterolemic rabbits before intimal accumulation of macrophages and T lymphocytes","volume":"17","author":"Sakai","year":"1997","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"4","key":"10.1016\/j.atherosclerosis.2019.06.903_bib50","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1161\/ATVBAHA.113.301655","article-title":"Chemokines in atherosclerosis","volume":"34","author":"Zernecke","year":"2014","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"3","key":"10.1016\/j.atherosclerosis.2019.06.903_bib51","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/S0002-9440(10)63471-2","article-title":"The role of interleukin-4 and interleukin-12 in the progression of atherosclerosis in apolipoprotein E-deficient mice","volume":"163","author":"Davenport","year":"2003","journal-title":"Am. J. Pathol."},{"issue":"12","key":"10.1016\/j.atherosclerosis.2019.06.903_bib52","first-page":"5338","article-title":"Eotaxin-2 increased toll-like receptor 4 expression in endothelial cells in vitro and exacerbates high-cholesterol diet-induced atherogenesis in vivo","volume":"8","author":"Tsai","year":"2016","journal-title":"Am. J. Transl. Res."},{"issue":"2","key":"10.1016\/j.atherosclerosis.2019.06.903_bib53","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/nrcardio.2009.228","article-title":"Monocytes in atherosclerosis: subsets and functions","volume":"7","author":"Woollard","year":"2010","journal-title":"Nat. Rev. Cardiol."},{"issue":"5838","key":"10.1016\/j.atherosclerosis.2019.06.903_bib54","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1126\/science.1142883","article-title":"Monitoring of blood vessels and tissues by a population of monocytes with patrolling behavior","volume":"317","author":"Auffray","year":"2007","journal-title":"Science"},{"issue":"12","key":"10.1016\/j.atherosclerosis.2019.06.903_bib55","doi-asserted-by":"crossref","first-page":"3037","DOI":"10.1084\/jem.20070885","article-title":"The healing myocardium sequentially mobilizes two monocyte subsets with divergent and complementary functions","volume":"204","author":"Nahrendorf","year":"2007","journal-title":"J. Exp. Med."},{"issue":"1","key":"10.1016\/j.atherosclerosis.2019.06.903_bib56","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1172\/JCI29950","article-title":"Ly-6Chi monocytes dominate hypercholesterolemia-associated monocytosis and give rise to macrophages in atheromata","volume":"117","author":"Swirski","year":"2007","journal-title":"J. Clin. Investig."},{"issue":"5940","key":"10.1016\/j.atherosclerosis.2019.06.903_bib57","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1126\/science.1175202","article-title":"Identification of splenic reservoir monocytes and their deployment to inflammatory sites","volume":"325","author":"Swirski","year":"2009","journal-title":"Science"},{"issue":"5","key":"10.1016\/j.atherosclerosis.2019.06.903_bib58","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1189\/jlb.72.5.921","article-title":"Role of CD80, CD86, and CTLA4 on mouse CD4(+) T lymphocytes in enhancing cell-cycle progression and survival after activation with PMA and ionomycin","volume":"72","author":"Mukherjee","year":"2002","journal-title":"J. Leukoc. Biol."}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915019313711?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915019313711?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,18]],"date-time":"2025-09-18T00:39:41Z","timestamp":1758155981000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021915019313711"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8]]},"references-count":58,"alternative-id":["S0021915019313711"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2019.06.903","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2019,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Stimulation of alpha 7 nicotinic acetylcholine receptor (\u03b17nAChR) inhibits atherosclerosis via immunomodulatory effects on myeloid cells","name":"articletitle","label":"Article Title"},{"value":"Atherosclerosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2019.06.903","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}